Genetic Sequencing tests in Dubai & UAE

Compare available Genetic Sequencing tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

256

Listed price range

2,600.00–5,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic Sequencing test prices

Showing 196–210 of 256 matching tests.

Genetic Sequencing diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5255 RAD21 Gene Cornelia de Lange Syndrome Type 4 Genetic Test This genetic test identifies pathogenic variants in the RAD21 gene associated with Cornelia de Lange syndrome type 4.	Whole Blood (EDTA) or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variants (CNVs)", "RAD21 gene sequence"] Parameters [] Preparation [] Indications ["Clinical suspicion of Cornelia de Lange syndrome type 4", "Family history of RAD21-related disorders", "Carrier screening for family members"] Measurement technique Confirm with laboratory Codes LOINC: 81265-0 ICD-10: Q87.1, Q87.81 Clinical summary This genetic test identifies pathogenic variants in the RAD21 gene associated with Cornelia de Lange syndrome type 4.
TEST-3482 REN Gene Renal Tubular Dysgenesis Genetic Test This test identifies pathogenic variants in the REN gene, confirming a diagnosis of autosomal recessive renal tubular dysgenesis.	Whole Blood (EDTA) or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the REN gene"] Parameters [] Preparation ["No specific patient preparation required"] Indications ["Suspected autosomal recessive renal tubular dysgenesis", "Perinatal presentation with renal failure symptoms", "Genetic counselling for potential prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 82949-8 ICD-10: Q63.8, N25.89, Z13.71 Clinical summary This test identifies pathogenic variants in the REN gene, confirming a diagnosis of autosomal recessive renal tubular dysgenesis.
TEST-2985 RET Gene Central Hypoventilation Syndrome, Congenital Genetic Test This test identifies pathogenic variants in the RET proto-oncogene associated with Congenital Central Hypoventilation Syndrome (CCHS) and Hirschsprung disease.	Whole blood (EDTA), FTA card, or extracted genomic DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the RET proto-oncogene", "Single-nucleotide variants", "Insertions", "Deletions"] Parameters [] Preparation ["No specific patient preparation required"] Indications ["Clinical suspicion of Congenital Central Hypoventilation Syndrome (CCHS)", "Clinical suspicion of Hirschsprung disease", "Family history of CCHS or Hirschsprung disease"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G47.35 Clinical summary This test identifies pathogenic variants in the RET proto-oncogene associated with Congenital Central Hypoventilation Syndrome (CCHS) and Hirschsprung disease.
TEST-6297 RFT1 Gene Congenital Disorder of Glycosylation Type 1N (CDG-1N) Genetic Test This genetic test identifies pathogenic variants in the RFT1 gene associated with Congenital Disorder of Glycosylation Type 1N (CDG-1N).	Whole Blood (EDTA) or Buccal Swab	21–28 Calendar Days (3–4 Weeks)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the RFT1 gene", "Full gene coverage including intron-exon boundaries"] Parameters [] Preparation ["No fasting required", "Mandatory pre-test genetic counselling session"] Indications ["Diagnosis of CDG-1N", "Carrier screening", "Family history investigation"] Measurement technique Confirm with laboratory Codes LOINC: 81264-5 ICD-10: E77.8 Clinical summary This genetic test identifies pathogenic variants in the RFT1 gene associated with Congenital Disorder of Glycosylation Type 1N (CDG-1N).
TEST-4792 RNASET2 Gene Leukoencephalopathy, Cystic Without Megalencephaly Genetic Test This genetic test evaluates the RNASET2 gene for pathogenic variants associated with cystic leukoencephalopathy without megalencephaly.	Peripheral whole blood (EDTA tube)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the RNASET2 gene", "Single nucleotide variants", "Small insertions/deletions", "Splicing aberrations"] Parameters [] Preparation ["No special preparation needed", "Ensure child is well-hydrated"] Indications ["Suspected cystic leukoencephalopathy without megalencephaly", "Family history of the disorder", "Genetic counseling for reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 94891-7 ICD-10: G93.49, E75.5, Z15.09 Clinical summary This genetic test evaluates the RNASET2 gene for pathogenic variants associated with cystic leukoencephalopathy without megalencephaly.
TEST-3043 ROR2 Gene Brachydactyly Type B1 Genetic Test This test identifies pathogenic variants within the ROR2 gene associated with autosomal dominant Brachydactyly Type B1.	Whole Blood (3–5 mL, EDTA tube), Extracted DNA (≥1 µg, ≥50 ng/µL), One Drop Blood on FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic single-nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy-number variations (CNVs)"] Parameters [] Preparation [] Indications ["Clinical suspicion of Brachydactyly Type B1", "Familial screening for ROR2-related Brachydactyly", "Reproductive planning for affected families"] Measurement technique Confirm with laboratory Codes LOINC: 81321-1 ICD-10: Q73.8 Clinical summary This test identifies pathogenic variants within the ROR2 gene associated with autosomal dominant Brachydactyly Type B1.
TEST-2388 ROR2 Gene Sequencing for Robinow Syndrome (Autosomal Recessive) Test This diagnostic test evaluates the ROR2 gene for pathogenic variants associated with autosomal recessive Robinow syndrome.	Peripheral Whole Blood (EDTA), Buccal Swab, or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ROR2 gene", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)"] Parameters [] Preparation ["A genetic counselling session to document a three-generation pedigree is mandatory before sample submission."] Indications ["Clinical suspicion of Robinow syndrome", "Family history of Robinow syndrome", "Genetic counseling for reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: Q87.1, Q87.2, Z14.8 Clinical summary This diagnostic test evaluates the ROR2 gene for pathogenic variants associated with autosomal recessive Robinow syndrome.
TEST-2877 RPS28 Gene Diamond‑Blackfan Anemia Type 15 with Mandibulofacial Dysostosis Genetic Test This diagnostic test evaluates the RPS28 gene for pathogenic variants linked to Diamond-Blackfan anemia type 15 and mandibulofacial dysostosis.	Whole Blood, Extracted DNA, FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the RPS28 gene"] Parameters [] Preparation ["No special preparation required", "Pre-test genetic counselling is mandatory", "Provide prior reports if available"] Indications ["Clinical suspicion of Diamond-Blackfan anemia", "Family history of confirmed RPS28 variant"] Measurement technique Confirm with laboratory Codes LOINC: 92811-2 ICD-10: D61.0, Q75.4 Clinical summary This diagnostic test evaluates the RPS28 gene for pathogenic variants linked to Diamond-Blackfan anemia type 15 and mandibulofacial dysostosis.
TEST-5724 RTN2 Gene (SPG12) Genetic Test This test identifies pathogenic variants within the RTN2 gene associated with autosomal dominant hereditary spastic paraplegia type 12 (SPG12).	Peripheral Whole Blood (3–5 mL EDTA) or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the RTN2 gene", "Single-nucleotide variants", "Small insertions/deletions", "Copy number changes"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed neurological or anti-spasticity medication unless advised by your neurologist"] Indications ["Suspected diagnosis of hereditary spastic paraplegia type 12 (SPG12)", "Family history of SPG12", "Genetic counseling for recurrence risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 21665-1 ICD-10: G11.4, Z15.89 Clinical summary This test identifies pathogenic variants within the RTN2 gene associated with autosomal dominant hereditary spastic paraplegia type 12 (SPG12).
TEST-3738 SARS2 Gene Genetic Test (NGS) for Hyperuricemia, Pulmonary Hypertension, Renal Failure, and Alkalosis This test identifies pathogenic variants in the SARS2 gene associated with HUPRA syndrome.	Peripheral Whole Blood, Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic single-nucleotide variants (SNVs)", "Small insertions and deletions (indels)", "SARS2 gene sequence"] Parameters [] Preparation ["No specific fasting required.", "No specific medication or diet restrictions."] Indications ["Individuals with unexplained concurrent hyperuricemia, pulmonary hypertension, and renal impairment.", "Individuals with a family history suggestive of mitochondrial disease.", "Confirmation of suspected HUPRA syndrome."] Measurement technique Confirm with laboratory Codes LOINC: 81264-9 ICD-10: E79.0, I27.0, N19, E87.3 Clinical summary This test identifies pathogenic variants in the SARS2 gene associated with HUPRA syndrome.
TEST-4220 SCN2A Gene Dravet Syndrome Genetic Test This genetic test detects pathogenic variants in the SCN2A gene, providing a molecular diagnosis for Dravet syndrome.	Whole blood, extracted DNA, or FTA card	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SCN2A gene", "Single nucleotide variants", "Small insertions/deletions", "Copy number variants"] Parameters [] Preparation ["No fasting required", "No medication adjustments required", "Pre-genetic counseling session mandatory"] Indications ["Individuals with suspected Dravet syndrome", "Family history of Dravet syndrome", "Asymptomatic siblings of affected individuals"] Measurement technique Confirm with laboratory Codes LOINC: 81378-8 ICD-10: G40.89 Clinical summary This genetic test detects pathogenic variants in the SCN2A gene, providing a molecular diagnosis for Dravet syndrome.
TEST-3557 SCNN1B Gene Pseudohypoaldosteronism Type 1 Genetic Test This genetic test identifies pathogenic variants in the SCNN1B gene associated with autosomal recessive pseudohypoaldosteronism type 1 (PHA1). It helps confirm the diagnosis in pat...	Whole blood (EDTA), extracted DNA, or capillary blood on FTA card	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SCNN1B gene pathogenic variants", "Copy number variations (deletions/duplications) in SCNN1B"] Parameters [] Preparation ["No special preparation or fasting is required."] Indications ["Suspected diagnosis of pseudohypoaldosteronism type 1 (PHA1)", "Infants with severe salt wasting, hyponatremia, and hyperkalemia"] Measurement technique Confirm with laboratory Codes LOINC: 83096-1 ICD-10: E26.8 Clinical summary This genetic test identifies pathogenic variants in the SCNN1B gene associated with autosomal recessive pseudohypoaldosteronism type 1 (PHA1). It helps confirm the diagnosis in patients with clinical features of severe salt wasting.
TEST-5153 SDHAF1 Gene Mitochondrial Complex II Deficiency Genetic Test This genetic test detects pathogenic variants in the SDHAF1 gene associated with Mitochondrial Complex II Deficiency.	Peripheral Whole Blood (EDTA) or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SDHAF1 gene", "Mitochondrial Complex II function (indirectly)"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any current medications"] Indications ["Suspected Mitochondrial Complex II Deficiency", "Family history of Leigh syndrome or related mitochondrial disorders", "Carrier testing for at-risk family members", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 92977-1 ICD-10: G31.89, E88.49 Clinical summary This genetic test detects pathogenic variants in the SDHAF1 gene associated with Mitochondrial Complex II Deficiency.
TEST-5805 SFTPD Gene Surfactant Metabolism Dysfunction Genetic Test This genetic test evaluates the SFTPD gene for pathogenic variants associated with surfactant metabolism dysfunction, a rare cause of neonatal respiratory distress.	Whole blood (EDTA), extracted DNA, or dried blood spot on FTA card	21–28 calendar days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SFTPD gene coding region variants", "Pathogenic variants linked to surfactant metabolism dysfunction"] Parameters [] Preparation [] Indications ["Suspected surfactant metabolism dysfunction", "Neonatal-onset interstitial lung disease", "Family planning for surfactant gene disorders"] Measurement technique Confirm with laboratory Codes LOINC: 97648-4 ICD-10: J84.89 Clinical summary This genetic test evaluates the SFTPD gene for pathogenic variants associated with surfactant metabolism dysfunction, a rare cause of neonatal respiratory distress.
TEST-2755 SIX3 Gene Holoprosencephaly Type 2 Genetic Test This test identifies germline mutations within the SIX3 gene associated with Holoprosencephaly Type 2 (HPE2). It provides comprehensive exon-level coverage and variant classificati...	Peripheral whole blood, buccal swab, or extracted DNA (FTA card acceptable)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SIX3 gene mutations", "Loss-of-function variants in SIX3"] Parameters [{"name": "Diagnostic Precision", "reference_range": "99.9% – Full exon & splice-site coverage"}] Preparation [] Indications ["Paediatric patients with craniofacial midline dysmorphology", "Families with known history of HPE2", "Neonates in NICU with suspected midline structural brain anomalies"] Measurement technique Confirm with laboratory Codes LOINC: 88040-1 ICD-10: Q04.2 Clinical summary This test identifies germline mutations within the SIX3 gene associated with Holoprosencephaly Type 2 (HPE2). It provides comprehensive exon-level coverage and variant classification according to ACMG/AMP guidelines.

Category overview

Genetic Sequencing: overview

Achieving a definitive diagnosis for multi-system or exceptionally rare disorders requires reading the deepest layers of your foundational biological code. As the pinnacle of our advanced Genetics department, Genetic Sequencing (including Whole Exome or Whole Genome testing) provides an incredibly detailed, high-resolution scan of your DNA. By leveraging state-of-the-art Next-Generation Sequencing technology, this expansive molecular screening helps uncover elusive genetic variants that standard tests miss, safely guiding your healthcare provider in tailoring highly personalized medical treatments and opening doors to advanced precision medicine. Consistently trusted for advanced genomic analysis across premier diagnostic labs in Dubai and the UAE, DNA Labs ensures strict patient confidentiality, exceptional analytical precision, and highly efficient reporting. Secure the definitive insights your health requires—book your genetic sequencing testing in UAE, arrange a secure clinical sample collection, or consult our dedicated medical genetics experts.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.